Clinical Trials

Clinical trials in nuclear medicine. Sorted by date of last update.

Title	Phase	Last Update
Lu-177-anti-PD-L1 sdAb in Metastatic Solid Tumors Early Phase 1 Last update: April 30	Early Phase 1	April 30
Radium-223 in Biochemically Recurrent Prostate Cancer Phase 2 Last update: April 30	Phase 2	April 30
Lu-177 Radiolabeled Monoclonal Antibody HuJ591 (Lu-177-J591) and Ketoconazole in Patients with Prostate Cancer Phase 2 Last update: April 30	Phase 2	April 30
HEAT Trial (HER2 Antibody Therapy with Lutetium-177) (RAD202) Early Phase 1 Last update: April 30	Early Phase 1	April 30
Radium-223 and Radiotherapy in Hormone-Naïve Men with Oligometastatic Prostate Cancer to Bone (RROPE) Phase 2 Last update: April 30	Phase 2	April 30
Lu-177-DOTATATE (Lutathera) in Combination with Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET) Phase 1 Last update: April 30	Phase 1	April 30
Evaluation of Neuroinflammation in Parkinson's Disease Using F-18-NOS PET/CT Early Phase 1 Last update: April 29	Early Phase 1	April 29
A Study to Assess Safety, Tolerability and Imaging Characteristics of [Ga-68]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [Lu-177]Lu-DPI-4452 in Participants with Unresectable Locally Advanced or Metastatic Solid Tumors Phase 1 Last update: April 29	Phase 1	April 29
Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer (Rad2Nivo) Phase 1 Last update: April 29	Phase 1	April 29
Lenvatinib Plus SIRT vs Lenvatinib in TACE-Refractory HCC Phase 2 Last update: April 29	Phase 2	April 29